Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dibromodulcitol.

× No keyword cloud information.

5 in total

1. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Authors: T E Elliott; R P Dinapoli; J R O'Fallon; J E Krook; J D Earle; R F Morton; R Levitt; L K Tschetter; B W Scheithauer; D M Pfeifle; D I Twito; R A Nelimark
Journal: J Neurooncol Date: 1997-07 Impact factor: 4.130

Review 2. Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors: R M Canetta; S K Carter
Journal: J Cancer Res Clin Oncol Date: 1984 Impact factor: 4.553

3. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors: D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

4. Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG).

Authors: V Erdélyi-Tóth; S Kerpel-Fronius; B Kanyár; S Eckhardt
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

5. Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG).

Authors: S Kerpel-Fronius; V Erdélyi-Tóth; F Gyergyay; I Hindy; Z Mechl; M Nekulová; S Somfai-Relle; P Kovács; G Ujj; B Kanyár
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

5 in total